0001593968-22-000513.txt : 20220222
0001593968-22-000513.hdr.sgml : 20220222
20220222160425
ACCESSION NUMBER: 0001593968-22-000513
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220222
DATE AS OF CHANGE: 20220222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mara Joseph Anthony Jr
CENTRAL INDEX KEY: 0001841148
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35280
FILM NUMBER: 22658022
MAIL ADDRESS:
STREET 1: C/O VERICEL CORPORATION
STREET 2: 64 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Vericel Corp
CENTRAL INDEX KEY: 0000887359
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943096597
STATE OF INCORPORATION: MI
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 7349305555
MAIL ADDRESS:
STREET 1: 64 SIDNEY ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: AASTROM BIOSCIENCES INC
DATE OF NAME CHANGE: 19960428
4
1
primary_01.xml
PRIMARY DOCUMENT
X0306
4
2022-02-18
0000887359
Vericel Corp
VCEL
0001841148
Mara Joseph Anthony Jr
C/O VERICEL CORPORATION
64 SIDNEY STREET
CAMBRIDGE
MA
02139
false
true
false
false
Chief Financial Officer
Restricted Stock Unit
2022-02-18
4
A
false
11018
0
A
Common Stock
11018
11018
D
Stock Option (right to buy)
34.90
2022-02-18
4
A
false
2865
0
A
2032-02-18
Common Stock
2865
2865
D
Stock Option (right to buy)
34.90
2022-02-18
4
A
false
61404
0
A
2032-02-18
Common Stock
61404
61404
D
Each Restricted Stock Unit (RSU) represents a contingent right to receive one share of common stock of Vericel Corporation.
These RSUs vest in four annual installments with the initial vesting of RSUs granted to the Reporting Person on February 18, 2023. The remaining RSUs will vest in annual installments on February 18, 2024, February 18, 2025, and February 18, 2026, respectively.
No expiration date for this type of award.
These options shall begin vesting on February 18, 2022 and shall continue to vest and become exercisable in equal quarterly installments over the course of the following four (4) year period.
/s/ Sean Flynn, as Attorney-in-Fact for Joseph Mara
2022-02-22